Rare diseases
Investigational molecules
Locations
474 conditions with trials, the busiest first
1 133 trials across Europe, recruiting first
Study on Sertraline with Immunochemotherapy for Patients with Advanced Gastroesophageal Cancer
AustriaStudy of Piperacillin/Tazobactam and Levofloxacin for Patients with COPD or Cystic Fibrosis
AustriaStudy on Ursodeoxycholic Acid to Prevent Recurrence of Acute Biliary Pancreatitis in Patients After Gallstone-Related Episode
SpainComparison of niraparib alone versus niraparib with bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel
BelgiumStudy of RR001 with Gemcitabine and Paclitaxel for Patients with Locally Advanced Pancreatic Cancer
ItalyStudy on Recurrent Colorectal Liver Metastases: Evaluating Calcium Folinate, Fluorouracil, Capecitabine, Oxaliplatin, and Irinotecan in a Drug Combination for Eligible Patients
The NetherlandsStudy of Ginisortamab with Nab-Paclitaxel and Gemcitabine or MEK Inhibitor for Patients with Metastatic Pancreatic Cancer
GermanyStudy Comparing Amivantamab and Chemotherapy Versus Cetuximab and Chemotherapy for Patients with Advanced Colorectal Cancer
BelgiumStudy on Preventing Blood Clots in Pancreatic Cancer Patients Using Tinzaparin Sodium and Enoxaparin Sodium During Treatment
FinlandStudy of Digitoxin with Chemotherapy for Patients with Inoperable Pancreatic Cancer
SwedenStudy Comparing FOLFOX (Oxaliplatin, Fluorouracil, Calcium Folinate) to Gemcitabine for Patients with Metastatic Pancreatic Cancer Not Suitable for FOLFIRINOX
FranceStudy on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors
BelgiumThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
